erdafitinib,cetrelimab
janssen
['bladder', 'cetrelimab', 'erdafitinib', 'norse', 'muc ,(-much)']
#norse study of #erdafitinib (n=43) vs erdafitinib + cetrelimab (n=44) in fgfr3+ metastatic #bladdercancer #muc pts showed an increase in orr 44.2% vs 54.5% but mdor was similar 9.7 mo vs 11.1mo #asco23 
Medical Oncologist, Investigator, Chief, #BladderCancer Section, #GenitourinaryTumors, NCI, NIH #RareTumors #PatientAdvocate, Latina. Views are my own